Robin Hofmann, Tamrat Befekadu Abebe, Johan Herlitz, Stefan K. James, Stefan K. James, David Erlinge, . . . DETO2X-SWEDEHEART Investigators. (2022). Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System-Insights From the Randomized DETO2X-AMI Trial. Frontiers Media S.A..
Chicago Style (17th ed.) CitationRobin Hofmann, et al. Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System-Insights From the Randomized DETO2X-AMI Trial. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationRobin Hofmann, et al. Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System-Insights From the Randomized DETO2X-AMI Trial. Frontiers Media S.A., 2022.